Guidance

Human papillomavirus (HPV): the green book, chapter 18a

Human papillomavirus (HPV) immunisation information for public health professionals, including updates.

• From: UK Health Security Agency
• Published: 20 March 2013
• Last updated: 20 June 2023 — See all updates

Documents

Human papillomavirus (HPV): the green book, chapter 18a

Ref: UKHSA gateway number 2019059

PDF, 199 KB, 21 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This chapter features:

• the history and epidemiology of the virus
• the HPV vaccine
• the dosage and schedule for the UK
• recommendations for the use of the vaccine
• contraindications and adverse reaction advice
• vaccine supply information

Human papillomavirus (HPV) is a double-stranded DNA virus that infects squamous epithelia including the skin and mucosae of the upper respiratory and anogenital tracts. There are approximately 100 types of HPV, of which about 40 infect the genital tract.

Published 20 March 2013
Last updated 20 June 2023 + show all updates

1. 20 June 2023

   Updated to include change from 2 doses to 1 dose for eligible individuals receiving HPV vaccine aged under 25 years from 1 September 2023.

2. 31 March 2022

   Updated in line with changes to vaccination schedule from 1 April 2022.

3. 12 July 2019

   Updated HPV chapter in preparation for the introduction of the HPV universal programme.

4. 5 June 2014

   Updated to reflect the forthcoming change in the vaccination schedule from 3 to 2 doses.

5. 19 April 2013

   Updated Body text to include link to NHS Choices.

6. 20 March 2013

   First published.